Their flagship product, the HeartLight Endoscopic Ablation System, is an FDA-approved catheter ablation technology that offers direct visualization and titratable laser energy, providing physicians with a new standard for AFib ablation. The system consists of a balloon catheter, endoscope, deflectable sheath, and integrated console, which together form a unique system offering precision and control in the treatment of cardiac arrhythmias. Since its founding in 1990, CardioFocus has treated more than 10,000 patients in the United States, Europe, and Japan, and continues to innovate in the field of ablation treatment for cardiac disorders.